<DOC>
	<DOCNO>NCT00913458</DOCNO>
	<brief_summary>Study evaluate whether sustained remission productivity subject early rheumatoid arthritis start etanercept plus methotrexate treatment .</brief_summary>
	<brief_title>Study Evaluating Etanercept Plus Methotrexate Early Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Diagnosis early rheumatoid arthritis . Methotrexate ( MTX ) naive . Active early rheumatoid arthritis time enrollment . Previous current treatment etanercept , tumor necrosis factoralpha ( TNF ) inhibitor , biologic agent . Concurrent treatment diseasemodifying antirheumatoid drug ( DMARD ) , within 4 week baseline . Concurrent treatment 1 nonsteroidal antiinflammatory drug ( NSAID ) baseline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>